COLL: Collegium Pharmaceutical Inc. filed SEC Form 8-K: Leadership Update
Stocks in this Quantisnow insightHealth Care
Keep researching COLL
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- COLL insider tradesEvery buy and sale reported by Collegium Pharmaceutical Inc. officers, directors and large holders.
- COLL earnings historyPast Collegium Pharmaceutical Inc. earnings releases, newest first.
- COLL financial statementsRevenue, profit, cash flow and balance sheet from Collegium Pharmaceutical Inc.'s SEC filings.
Quantisnow market dataNASDAQ
COLL
Collegium Pharmaceutical Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2015
Get push alerts for COLL
Full COLL profile on Quantisnow Follow COLL and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time